Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Interim results from the phase 2 study FIDES-01 Meeting Abstract
| Authors: | Javle, M. M.; Abou-Alfa, G. K.; Macarulla, T.; Personeni, N.; Adeva, J.; Bergamo, F.; Malka, D.; Vogel, A.; Knox, J. J.; Jeffry Evans, T. R.; Dimova-Dobreva, M.; Harris, W. P.; Saulay, M.; Engelhardt, M.; Braun, S.; Busset, M. D. D.; Borad, M. J. |
| Abstract Title: | Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Interim results from the phase 2 study FIDES-01 |
| Meeting Title: | 2022 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2022 Jan 20-22 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-01 |
| Language: | English |
| ACCESSION: | WOS:000770995900413 |
| DOI: | 10.1200/JCO.2022.40.4_suppl.427 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 427 -- Meeting was conducted online as well as in person -- Source: Wos |
